LUSH LASHES with LATISSE™
- Posted on: Jun 3 2009
Ophthalmologists are once again at the forefront of innovation for cosmetic facial procedures. From Botox to Juvéderm, eye physicians have been regarded as the experts in the original research and development of injectable, anti-wrinkle treatments. Now, Latisse, the first and only FDA-approved treatment for inadequate or sparse, thinning eyelashes, has been added to the options for facial enhancement. Its origin is directly from a glaucoma medication that ophthalmologists have been using for the treatment of elevated eye ressure.
Latisse solution is a prescription medication used to grow longer, thicker and darker eyelashes. Its effect is gradual, and significant improvement in lash growth can be seen by two months. At the onset of therapy, and at eight and sixteen weeks, I photograph the eyelash area, examine the eyelid and check the eye pressure in each eye with a specialized, high magnification microscope. Patients who have a history of elevated or borderline eye pressure, patients who are taking glaucoma medication or patients with a family history of glaucoma should discuss this before considering treatment with Latisse. Latisse solution is applied with a sterile applicator to the upper eyelid only, and only once a day as directed.
As an ophthalmologist and fellowship-trained oculoplastic surgeon, I recommend that patients consider the credentials of the treating physician, their experience with aesthetic procedures, and their knowledge of eye/eyelid anatomy. Eye plastic surgeons are uniquely qualified as specialists of the eyelid and are able to monitor the eye pressure or any potential ocular/lid adverse effects.
Please visit our Latisse page under our cosmetics tab for more information or to view the new Latisse™ commercial featuring Brooke Shields.
Angela Veloudios MD, F.A.C.S.
Posted in: Cosmetic